Skip to content

A case-control study on the correlation between allergic rhinitis and nasopharyngeal carcinoma

A case-control study on the correlation between allergic rhinitis and nasopharyngeal carcinoma

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800016447
Enrollment
Unknown
Registered
2018-06-01
Start date
2018-07-01
Completion date
Unknown
Last updated
2018-06-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nasopharyngeal carcinoma

Interventions

Sponsors

Guangdong Provincial Hospital of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 120 Years

Inclusion criteria

Inclusion criteria: NPC case group 1. Diagnosis and clinical staging are in line with international and domestic standards for NPC diagnosis; 2. Older than 18 years, no gender limited, the participant himself/herself or his/her family informed consent, and they are willing to cooperate with the investigation; 3. The participant had complete demographic data, all participants are from high incidence of NPC in the South of China (Guangdong Province, Guangxi Province, Jiangxi Province, Hunan Province, Fujian Province and Sichuan Province). Non-NPC control group: 1. Participant without NPC or other medical history of cancer or a healthy person; 2. Older than18 years, no gender limited, the participant himself/herself or his/her family informed consent, and they are willing to cooperate with the investigation; 3. The participant had complete demographic data and he/she is from high incidence of NPC in the South of China (Guangdong Province, Guangxi Province, Jiangxi Province, Hunan Province, Fujian Province and Sichuan Province).

Exclusion criteria

Exclusion criteria: NPC group: 1. Retreatment or recurrence of NPC patients, or cases that do not meet international and domestic guidelines. 2. The participant himself /herself or his/her family refused to sign the informed consent; 3. Under 18 years; 4. The participant with a history of other malignancies. Control group: 1. Malignancy history; 2. The participant refused to sign the informed consent; 3. Under 18 years.

Design outcomes

Primary

MeasureTime frame
odds ratio;

Countries

China

Contacts

Public ContactQiulan Luo

Guangdong Provincial Hospital of Chinese Medicine

doctorluoql77@gzucm.edu.cn+86 13760713695

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026